Skip to content
CoinNetwork NL

The Zimbabwean Government Declines ‘Unbalanced’ US Healthcare Assistance Agreement Over Information Concerns

Medical aid illustration
The proposed US financial assistance was aimed at programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has turned down a substantial US healthcare agreement valued at $367m (272 million pounds) spanning five years over Washington's request for confidential biological samples.

This move came to light following a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".

An official spokesperson has since stated that the US was seeking genetic material for scientific study and commercial purposes while was not willing to guarantee the benefits from any future medical innovations.

"We must now begin the difficult and regrettable process of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the United States had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has urged further negotiations to find a agreement suitable to all parties so the country's critical HIV programme can proceed.

Wider Background

Zimbabwe's decision follows a similar case in Kenya, where a court blocked a related deal with the US after legal challenges were raised about the safety of citizens' health data.

Since returning to the presidency recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.

The agency had administered assistance for the US government, but Trump claimed its spending was "inefficient" and his government was pursuing direct bilateral agreements to boost transparency and accountability.

Based on reports, Sixteen nations in Africa have so far agreed to similar health pacts, representing more than $18.3bn of fresh investment.

Details of the Rejected Agreement

This assistance for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this cooperation might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million presently on antiretroviral therapy via US-supported initiatives," the Ambassador said.

However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".

"Zimbabwe was being asked to share its genetic material and health information over an extended period, with no corresponding assurance of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that provided information," Mangwana explained.

"Put simply, our nation would supply the basic resources for medical research without any certainty that the final treatments would be available to our population if a new pandemic emerge."

National Interest and International Frameworks

He also pointed out that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were upending systems already set up through the international health agency.

The spokesperson cited its Pathogen Access and Benefit Sharing framework created to manage future global health emergencies.

"This system is designed to ensure that when a nation contributes its samples, the resulting advantages – including medicines and cures – are shared equitably, not commercialised solely by those with the capability to create them."

Zimbabwe's reservations over the US deal "are not meant as opposition to America," he added.

"We encourage ongoing dialogue with our US partners on how future collaboration could be structured in a manner that honours the sovereignty and interests of each country."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but urged that negotiations need to persist considering much of the country's Aids initiatives relied on foreign aid.

"In cases where technical issues arise, such as those relating to data governance or implementation frameworks, these can often be addressed via detailed discussion and negotiated safeguards," it said.

The halted deal emphasises the continuing challenges between receiving much-needed foreign assistance and protecting a country's data in an ever more data-driven world.

MN
About the author

Mrs. Nancy Taylor

A blockchain analyst and crypto journalist based in Amsterdam, covering market trends and regulatory developments.

CoinNetwork NL

Type to search articles.